These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17584960)

  • 1. Release of glutamate decarboxylase-65 into the circulation by injured pancreatic islet beta-cells.
    Waldrop MA; Suckow AT; Marcovina SM; Chessler SD
    Endocrinology; 2007 Oct; 148(10):4572-8. PubMed ID: 17584960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma GAD65, a Marker for Early β-Cell Loss After Intraportal Islet Cell Transplantation in Diabetic Patients.
    Ling Z; De Pauw P; Jacobs-Tulleneers-Thevissen D; Mao R; Gillard P; Hampe CS; Martens GA; In't Veld P; Lernmark Å; Keymeulen B; Gorus F; Pipeleers D
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2314-21. PubMed ID: 25816051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Finding GAD: early detection of beta-cell injury.
    Hinke SA
    Endocrinology; 2007 Oct; 148(10):4568-71. PubMed ID: 17876036
    [No Abstract]   [Full Text] [Related]  

  • 4. A highly sensitive immunoassay resistant to autoantibody interference for detection of the diabetes-associated autoantigen glutamic acid decarboxylase 65 in blood and other biological samples.
    Waldrop MA; Suckow AT; Hall TR; Hampe CS; Marcovina SM; Chessler SD
    Diabetes Technol Ther; 2006 Apr; 8(2):207-18. PubMed ID: 16734550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of single high-dose streptozotocin with partial pancreatectomy combined with low-dose streptozotocin for diabetes induction in rhesus monkeys.
    Jin X; Zeng L; He S; Chen Y; Tian B; Mai G; Yang G; Wei L; Zhang Y; Li H; Wang L; Qiao C; Cheng J; Lu Y
    Exp Biol Med (Maywood); 2010 Jul; 235(7):877-85. PubMed ID: 20558842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of BB rat beta cells as determined by dose-responses to the cytotoxic effects of streptozotocin and alloxan.
    Yale JF; Grose M; Videtic GM; Marliss EB
    Diabetes Res; 1986 Mar; 3(3):161-7. PubMed ID: 2940045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of glutamic acid decarboxylase (GAD65) in pancreatic islets and its in vitro and in vivo degradation kinetics in serum using a highly sensitive enzyme immunoassay.
    Schlosser M; Walschus U; Klöting I; Walther R
    Dis Markers; 2008; 24(3):191-8. PubMed ID: 18334741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The orphan nuclear receptor small heterodimer partner negatively regulates pancreatic beta cell survival and hyperglycemia in multiple low-dose streptozotocin-induced type 1 diabetic mice.
    Noh JR; Hwang JH; Kim YH; Kim KS; Gang GT; Kim SW; Kim DK; Shong M; Lee IK; Choi HS; Lee CH
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1538-45. PubMed ID: 23680671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an Enhanced Sensitivity Bead-Based Immunoassay for Real-Time In Vivo Detection of Pancreatic β-Cell Death.
    Costa OR; Stangé G; Verhaeghen K; Brackeva B; Nonneman E; Hampe CS; Ling Z; Pipeleers D; Gorus FK; Martens GA
    Endocrinology; 2015 Dec; 156(12):4755-60. PubMed ID: 26431226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Damaged rat beta cells discharge glutamate decarboxylase in the extracellular medium.
    Smismans A; Ling Z; Pipeleers D
    Biochem Biophys Res Commun; 1996 Nov; 228(2):293-7. PubMed ID: 8920908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptozotocin diabetes. Correlation with extent of depression of pancreatic islet nicotinamide adenine dinucleotide.
    Anderson T; Schein PS; McMenamin MG; Cooney DA
    J Clin Invest; 1974 Sep; 54(3):672-7. PubMed ID: 4369217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoassay for glutamic acid decarboxylase-65.
    Hao W; Daniels T; Pipeleers DG; Smismans A; Reijonen H; Nepom GT; Lernmark A
    Diabetes Technol Ther; 1999; 1(1):13-20. PubMed ID: 11475299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Β-cells of rats pancreas and their supposed precursors during alloxan diabetes and after the action of Plaferon LB.
    Latsabidze I; Machavariani T; Gachechiladze I; Gvamichava T; Kavtiashvili K
    Georgian Med News; 2011 Sep; (198):40-5. PubMed ID: 22156675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LC-MS/MS identification of doublecortin as abundant beta cell-selective protein discharged by damaged beta cells in vitro.
    Jiang L; Brackeva B; Stangé G; Verhaeghen K; Costa O; Couillard-Després S; Rotheneichner P; Aigner L; Van Schravendijk C; Pipeleers D; Ling Z; Gorus F; Martens GA
    J Proteomics; 2013 Mar; 80():268-80. PubMed ID: 23337804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamate decarboxylase and GABA in pancreatic islets: lessons from knock-out mice.
    Kash SF; Condie BG; Baekkeskov S
    Horm Metab Res; 1999 May; 31(5):340-4. PubMed ID: 10422732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
    Sternesjö J; Welsh N; Sandler S
    Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase.
    Jun HS; Chung YH; Han J; Kim A; Yoo SS; Sherwin RS; Yoon JW
    Diabetologia; 2002 May; 45(5):668-76. PubMed ID: 12107747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early enhanced beta cell replication in normoglycaemic Wistar rats in response to a subdiabetogenic dose of streptozotocin.
    Ziegler B; Lucke S; Besch W; Hahn HJ
    Exp Clin Endocrinol; 1989 Apr; 93(1):1-10. PubMed ID: 2525479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
    Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.
    Pietropaolo M; Yu S; Libman IM; Pietropaolo SL; Riley K; LaPorte RE; Drash AL; Mazumdar S; Trucco M; Becker DJ
    Pediatr Diabetes; 2005 Dec; 6(4):184-92. PubMed ID: 16390386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.